HI HB2024 | 2024 | Regular Session
Status
Spectrum: Slight Partisan Bill (Democrat 3-1)
Status: Introduced on January 22 2024 - 25% progression, died in committee
Action: 2024-01-24 - Referred to HLT, CPC, referral sheet 2
Pending: House Health Committee
Text: Latest bill text (Introduced) [HTML]
Status: Introduced on January 22 2024 - 25% progression, died in committee
Action: 2024-01-24 - Referred to HLT, CPC, referral sheet 2
Pending: House Health Committee
Text: Latest bill text (Introduced) [HTML]
Summary
Beginning on January 1, 2025, permits manufacturers of investigational drugs or biological products to make these drugs and products available to terminally ill patients under certain conditions.
Title
Relating To Access To Treatment For Terminally Ill Patients.
Sponsors
History
| Date | Chamber | Action |
|---|---|---|
| 2024-01-24 | House | Referred to HLT, CPC, referral sheet 2 |
| 2024-01-22 | House | Introduced and Pass First Reading. |
| 2024-01-19 | House | Pending introduction. |
Same As/Similar To
SB2023 (Same As) 2024-01-17 - Referred to HHS, CPN/JDC.
Subjects
Hawaii State Sources
| Type | Source |
|---|---|
| Summary | https://www.capitol.hawaii.gov/session/measure_indiv.aspx?billtype=HB&billnumber=2024&year=2024 |
| Text | https://www.capitol.hawaii.gov/sessions/session2024/bills/HB2024_.HTM |
